Pharmaceuticals & Therapeutics

CosmoFarm hits a $60M run-rate with advanced robotics, but its record growth is set against the backdrop of parent Cosmos Health's 'going concern' warning.

AbbVie's latest dividend increase isn't just good news for investors; it's a window into the pharma giant's strategy for navigating future challenges.

Morningstar Farms' recall over plastic contamination is more than a consumer alert; it's a stress test for the entire plant-based food industry's rapid growth.

AdventHealth is pouring $214M into its Carrollwood hospital. It's not just a local expansion—it's a strategic move in a high-stakes race to serve Florida's boom.

Beyond the wrapper, Latvian confectioners are leveraging EU backing and sustainability claims to tap into Canada's conscious consumer market. But do the ethics match the indulgence?

The consumer safety watchdog is moving its HQ to downtown D.C. We dissect the claims of taxpayer savings, the strategic power play, and the human cost.

A local roofing expert's advice on costly repairs reveals a larger trend: how specialized knowledge and innovative media are reshaping community business strategy.

A scientific shift from replacement to regeneration is fueling a market set to surpass $100B. But can new players navigate the regulatory and commercial hurdles?

A new study reveals consumer interest in regenerative agriculture is surging, but it's driven by personal health and nutrition, not just environmentalism.

In one of America's wealthiest corridors, a hunger crisis is growing. A unique partnership shows how corporate, non-profit, and community forces unite to help.

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

A new initiative promises to help rural clinics access federal funds for telehealth, but it’s also a savvy growth play for the tech company behind it.

Brewer Science's acquisition of a key chemical unit is more than a deal; it's a strategic fortification of the global semiconductor supply chain.

A small Colorado firm's award-winning floor, made from waste shells and backed by the military, signals a major shift in our reliance on fossil fuels.

As medical spas boom, companies like Cosmedical are empowering doctors to sell their own brands, betting on curated regimens to boost both patient results and profits.

A new study of 100M insurance claims reveals a shocking failure: nearly 9 in 10 women in some states get no osteoporosis care after a fracture. Why?

With the hire of a crisis-tested litigator, law firm SBSB is betting on deep operational insight to navigate the increasingly treacherous waters of maritime law.

Beyond amyloid plaques, a new therapy tackles Alzheimer's by reducing inflammation. Longeveron's latest data offers a glimpse into a regenerative future.

New real-time imaging gives surgeons a 3D molecular map of cancer in the OR, poised to end the emotional and physical toll of reoperations for many.

Takeda is deploying Boltz's frontier AI across its labs, betting that AI agents can accelerate medicine by acting as a creative partner for scientists.